Study reference 226179: The study drug in this study is being developed for the treatment of inflammatory diseases like asthma.. This study consists of 3 nights in-house, 2 outpatient visits and 1 follow–up telephone call. We are looking for healthy & asthmatic male and female (of non-childbearing potential) volunteers (aged 18-65). Volunteers must be non-smokers for at least 6 months prior to screening. The inconvenience allowance for this study is £1,250.